Friday's Medical PRs. VITAMIN SHOPPE 72 HOUR D

Friday's Medical PRs.

• VITAMIN SHOPPE 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Vitamin Shoppe, Inc.
  10:00 pm - Business Wire


• Calyx Announces Second and Final Closing of Non-Brokered Private Placement
  6:45 pm - Marketwire


• Dr. Douglas M. Weissman, MD, FACP is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine
  6:02 pm - PR Newswire


• Summer is the Perfect Time for a Smile that Shines from Hamlin Dental Group
  5:00 pm - PR Newswire


• XenoPort Announces New Employment Inducement Awards
  5:00 pm - Business Wire


• Find Out about Laser Vein or Hair Removal before Bikini Season is Over
  4:46 pm - PR Newswire


• Back Pain Can Spread after Improper Treatment, says S.M. Rezaian, MD, FRCS, FICS, PhD
  4:44 pm - PR Newswire


• Paladin Labs Inc. and Bioniche Life Sciences Inc. Officially Close Debt Refinancing and Urocidin(TM) Licensing Deals
  4:12 pm - Marketwire


• PerkinElmer to Hold Earnings Call on Thursday, August 1, 2013
  4:05 pm - Business Wire


• Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  4:00 pm - PR Newswire


• Paladin Labs Inc. and Bioniche Life Sciences Inc. Officially Close Debt Refinancing and Urocidin(TM) Licensing Deals
  3:35 pm - Marketwire


• Laboratoires Paladin Inc. et Bioniche Life Sciences Inc. concluent officiellement le refinancement de la dette et signent une entente de licence pour Urocidin(MC)
  3:35 pm - Marketwire


• Biosign Investor Conference Call scheduled
  3:08 pm - CNW Group


• Paladin Labs Inc. and Bioniche Life Sciences Inc. Officially Close Debt Refinancing and Urocidin™ Licensing Deals
  3:06 pm - PR Newswire


• Aspen Dental And Stewart-Haas Racing Celebrate Smiles During NASCAR Sprint Cup Coke Zero 400 Powered By Coke At Daytona International Speedway
  3:05 pm - PR Newswire


• Researchers at Children’s Hospital Los Angeles Discover a Potential Structural Basis for ADHD in Brain of Preterm Newborns
  2:16 pm - Business Wire


• Research and Markets: Global Spine Surgery Devices Market is Poised to Grow at a CAGR of 5.1% to Reach $14,833 Million by 2017
  1:24 pm - Business Wire


• Research and Markets: Global Vena Cava Filters Market 2012-2016 with C.R. Bard Inc., Cook Medical Inc., and Cordis Corp. Dominating
  1:18 pm - Business Wire


• Research and Markets: Allergan Limited - Product Pipeline Review - 2013 Available Now for Analysis
  12:39 pm - Business Wire


• Regence Offers Oregon Employers Big Benefits Through New Professional Employer Organization Agreement
  12:05 pm - PR Newswire


• Research and Markets: Tapping Social Media for Clinical Trial Recruitment - 2013: 80% of Clinical Trials Are Currently Failing To Achieve Enrollment Goals
  11:58 am - Business Wire


• CorMedix Receives CE Mark for Neutrolin® Catheter Lock Solution
  11:05 am - Business Wire


• CLINATEC Chairman Alim-Louis Benabid Honored by Michael J. Fox Foundation for Pioneering Work in Treating Parkinson’s Disease
  10:56 am - Business Wire


• Rafarma Pharmaceuticals, Inc. (RAFA) Enters Into New Production Contract for Para-Aminosalicylic Acid
  10:27 am - Marketwire


• Beverly Hills Cosmetic Dentist, Parsa Zadeh DDS, Offers Various Teeth Whitening Treatments
  10:00 am - GlobeNewswire


• Medical Tourism Association(R)-University of Miami Partnership Offering First Continuing Education Credits in Medical Tourism
  9:47 am - Marketwire


• Research and Markets: PharmaPoint: Dermatophytic Onychomycosis (DO) - Current and Future Players
  9:19 am - Business Wire


• Leonhardt Ventures to Present Cardiovascular and Heart Disease Technology Showcase @ University of Minnesota
  9:15 am - PR Newswire


• Research and Markets: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain
  9:13 am - Business Wire


• Research and Markets: PharmaPoint: Dermatophytic Onychomycosis (DO) - US Drug Forecast and Market Analysis to 2022
  9:12 am - Business Wire


• Northridge Dentist, Dr. Ariz, is Now Offering Treatments for Sleep Apnea
  9:00 am - PR Newswire


• Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
  8:30 am - GlobeNewswire


• Elsevier Promotes Local Research Efforts in Pakistan Through "Quiz for Science"
  8:01 am - PR Newswire


• U.S. FDA Approves Zubsolv® for the Maintenance Treatment of Opioid Dependence
  8:00 am - PR Newswire


• Research and Markets: Germany Health and Wellness Industry Outlook to 2017 - Health Clubs and Spas to Witness Strong Growth
  7:43 am - Business Wire


• Registration is Open for the Dotmatics UGM 2013
  7:42 am - Business Wire


• Theragenics Signs Brachytherapy Supply and Reseller Agreement with UK-Based Accelyon
  7:30 am - Business Wire


• Mary K. Pendergast Appointed to Impax Laboratories Board of Directors
  7:30 am - Business Wire


• Top Vivus shareholder says proxy firm ISS backs three of nine board nominees
  7:16 am - Reuters


• Two Leading Proxy Advisory Firms Reject FMC's Attempt to Take Control of VIVUS's Board
  7:00 am - GlobeNewswire


• Cyclacel Pharmaceuticals to Present at the JMP Securities Healthcare Conference 2013
  7:00 am - GlobeNewswire


• Research and Markets: Incontinence Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2019
  6:47 am - Business Wire


• Research and Markets: Cardiovascular Disease - Pipeline Review, H1 2013
  6:21 am - Business Wire


• ISS and Egan Jones Recommend That Vivus Stockholders Vote for First Manhattan’s Nominees for Election to Vivus Board
  6:00 am - Business Wire


• Research and Markets: Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2013
  5:24 am - Business Wire


• Research and Markets: Pseudomonas Infections - Pipeline Review, H1 2013
  5:05 am - Business Wire


• Baxter Presents ADVATE Data on Prophylaxis Management and Efficacy for Hemophilia A Patients
  3:00 am - Business Wire


• China starts probe into Tetra Pak 'dominance': media
  2:57 am - Reuters